Tango Therapeutics, Inc. financial data

Symbol
TNGX on Nasdaq
Industry
Pharmaceutical Preparations
Location
201 Brookline Avenue, Suite 901, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
BCTG Acquisition Corp. (to 8/9/2021)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 748 % -1.32%
Debt-to-equity 60.5 % -9.95%
Return On Equity -44.4 % -4.75%
Return On Assets -27.6 % -9.12%
Operating Margin -339 % +27.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 107M shares +21%
Common Stock, Shares, Outstanding 107M shares +21%
Entity Public Float 177M USD -41.3%
Common Stock, Value, Issued 107K USD +21.6%
Weighted Average Number of Shares Outstanding, Basic 108M shares +22.7%
Weighted Average Number of Shares Outstanding, Diluted 108M shares +22.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 37.2M USD +49.7%
Research and Development Expense 125M USD +14.2%
General and Administrative Expense 38.2M USD +22.2%
Operating Income (Loss) -126M USD -8.76%
Nonoperating Income (Expense) 14.7M USD +190%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -111M USD -0.5%
Income Tax Expense (Benefit) 174K USD +222%
Net Income (Loss) Attributable to Parent -112M USD -0.61%
Earnings Per Share, Basic -1.11 USD/shares +11.9%
Earnings Per Share, Diluted -1.11 USD/shares +11.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 61.2M USD +6.83%
Marketable Securities, Current 282M USD +2.19%
Accounts Receivable, after Allowance for Credit Loss, Current 2M USD 0%
Assets, Current 352M USD +2.63%
Property, Plant and Equipment, Net 9.52M USD -14.3%
Operating Lease, Right-of-Use Asset 42.1M USD -8.95%
Other Assets, Noncurrent 11K USD -42.1%
Assets 406M USD +0.61%
Accounts Payable, Current 3.9M USD -38.1%
Employee-related Liabilities, Current 2.86M USD +40.1%
Contract with Customer, Liability, Current 23.1M USD -32.2%
Liabilities, Current 42.8M USD -20.3%
Contract with Customer, Liability, Noncurrent 62.8M USD -25.3%
Operating Lease, Liability, Noncurrent 36.2M USD -6.62%
Liabilities 142M USD -19.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -257K USD +88.3%
Retained Earnings (Accumulated Deficit) -409M USD -37.5%
Stockholders' Equity Attributable to Parent 264M USD +16.4%
Liabilities and Equity 406M USD +0.61%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.9M USD -8.45%
Net Cash Provided by (Used in) Financing Activities 43M USD +58779%
Net Cash Provided by (Used in) Investing Activities -11.2M USD -136%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 107M shares +21%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.08M USD -85.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 63.7M USD +5.04%
Deferred Tax Assets, Valuation Allowance 113M USD +39.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 127M USD +32.6%
Operating Lease, Liability 38.9M USD -5.38%
Depreciation 625K USD +7.57%
Payments to Acquire Property, Plant, and Equipment 195K USD -68.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -110M USD +0.06%
Lessee, Operating Lease, Liability, to be Paid 55.5M USD -9.31%
Property, Plant and Equipment, Gross 16.1M USD +5.14%
Operating Lease, Liability, Current 2.07M USD -21.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.61M USD +1.17%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.1M USD +2.55%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.6M USD -17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.78M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 16.6M USD +118%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.95M USD +3%
Operating Lease, Payments 5.19M USD +6227%
Additional Paid in Capital 674M USD +27.9%
Deferred Tax Assets, Net of Valuation Allowance 14M USD -7.09%
Share-based Payment Arrangement, Expense 21.6M USD +41.6%